Clinical Trial Update: OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP [Phase 4]

View source ↗

Summary

A Phase 4 trial update on minimally-invasive surfactant therapy for preterm infants 25-28 weeks on CPAP, investigating prevention or management of Bronchopulmon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Snippet

Sponsor: Menzies Institute for Medical Research | Conditions: Bronchopulmonary Dysplasia | Phase 4 | Status: UNKNOWN